Is DMII research on Rallies investment advice?

No. Rallies provides research, data, and educational context for DMII. It does not provide personalized investment advice.

DMII (Drugs Made In America Acquisition II Corp. Ordinary Shares) Stock Analysis - Financials

Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) is a publicly traded the market company. As of August 14, 2026, DMII trades at $10.13 with a market cap of $645.28M and a P/E ratio of 0.00. DMII moved +0.00% today. Year to date, DMII is +2.63%; over the trailing twelve months it is flat. Its 52-week range spans $9.86 to $10.20. Rallies surfaces DMII's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are DMII's key financials?

DMII financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. DMII recently traded at $10.13. Market cap is $645.28M. P/E ratio is 0.00. Revenue is $0.

DMII Key Metrics

Key financial metrics for DMII
Metric	Value
Price	$10.13
Market Cap	$645.28M
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$10.20
52-Week Low	$9.86
Volume	31
Avg Volume	0
Revenue (TTM)	$0
Net Income	$4.19M
Gross Margin	0.00%

DMII Analyst Consensus

DMII analyst coverage data. Average price target: $0.00.

Common questions about DMII

What are DMII's key financials?: DMII financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. DMII recently traded at $10.13. Market cap is $645.28M. P/E ratio is 0.00. Revenue is $0.
Is DMII research on Rallies investment advice?: No. Rallies provides research, data, and educational context for DMII. It does not provide personalized investment advice.